(Q41410427)

English

REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors

scientific article published on 12 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 September 2017

REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors (English)

1 reference

Europe PubMed Central

30 September 2017

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Don G Morris

1

1 reference

Europe PubMed Central

30 September 2017

Xiaolan Feng

2

1 reference

Europe PubMed Central

30 September 2017

Lisa M DiFrancesco

3

1 reference

Europe PubMed Central

30 September 2017

Kevin Fonseca

4

1 reference

Europe PubMed Central

30 September 2017

Peter A Forsyth

5

1 reference

Europe PubMed Central

30 September 2017

Alexander H Paterson

6

1 reference

Europe PubMed Central

30 September 2017

Matt C Coffey

7

1 reference

Europe PubMed Central

30 September 2017

Brad Thompson

8

1 reference

Europe PubMed Central

30 September 2017

publication date

12 August 2012

1 reference

Europe PubMed Central

30 September 2017

Investigational New Drugs

1 reference

Europe PubMed Central

30 September 2017

31

1 reference

Europe PubMed Central

30 September 2017

3

1 reference

Europe PubMed Central

30 September 2017

696-706

1 reference

Europe PubMed Central

30 September 2017

https://scigraph.springernature.com/pub.10.1007/s10637-012-9865-z

0 references

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Recent progress in the battle between oncolytic viruses and tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Viruses causing common respiratory infection in man. IV. Reoviruses and Adenoviruses

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Reovirus-based therapy for cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Reovirus therapy of lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Reovirus oncolysis of human breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Reovirus as an oncolytic agent against experimental human malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9865-Z

21 January 2018

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncolytic reovirus against ovarian and colon cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reovirus infections in human volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ras oncogenes in human cancer: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel intravesical therapy for superficial bladder cancer in an orthotopic model: oncolytic reovirus therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22886613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-012-9865-Z

1 reference

Europe PubMed Central

30 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41410427&oldid=2096888034"